Panel Discussion | Digital Heath Apps in Clinical Trials: Ready for Prime Time?

Tuesday, March 11, 2025

11:30 AM – 12:00 PM ET

Panel Moderator(s)

Jodi J. Akin, MS

Founder/BOD
Hawthorne Effect, Inc.
Alamo, California, United States

Disclosure information not submitted.
Joaquin E. Cigarroa, MD

Director, Knight Cardiovascular Institute
OHSU Knight Cardiovascular Institute
Portland, Oregon, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Mona Advani, M.Sc., MBA

Principal Regulatory Consultant
CardioMed Device Consultants
HERNDON, Virginia, United States

Disclosure(s): No financial relationships to disclose
Robert M. Califf, MD

Commissioner of the Food and Drug Administration
Food and Drug Administration
Durham, North Carolina, United States

Disclosure information not submitted.
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
David F. Kong, MD, AM, DMT

Associate Professor of Medicine
Duke University
Durham, North Carolina, United States

Disclosure information not submitted.
Ernest Spitzer, MD

Chief Executive Officer
Cardialysis B.V.
Rotterdam, Zuid-Holland, Netherlands

Disclosure(s): Abbott Labs: Grant/Research Support (Terminated, December 31, 2023); Biosensors International: Grant/Research Support (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Cardialysis: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Medtronic: Grant/Research Support (Ongoing); MicroPort Medical: Grant/Research Support (Terminated, June 30, 2024); Philips Healthcare: Grant/Research Support (Ongoing); Pie Medical: Grant/Research Support (Ongoing); shenqi Medical Technology: Grant/Research Support (Ongoing); Siemens: Grant/Research Support (Ongoing)
Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)
Robert W. Yeh, MD, MSc

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.

Disclosure(s):

Joaquin E. Cigarroa, MD: No financial relationships to disclose

Mona Advani, M.Sc., MBA: No financial relationships to disclose

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)